JakartaGlobe-Oct 16, 2020

A team from the Food and Drug Control Agency, or BPOM, left for China on Thursday to inspect production process at three Covid-19 vaccine factories, from which Indonesia has secured a supply commitment. The team will visit the production sites of Sinovac, Sinofarm and Cansino vaccines to make sure that they are high in quality for the intended use and manufactured in compliance with good manufacturing practice, according to BPOM’s drug registration director Lucia Rizka Andalusia.“The team also comprises officials from the Health Ministry, the Indonesian Ulema Council (MUI) and state-run pharmaceutical firm Bio Farma,” Lucia said in a video conference.

Read more at: https://jakartaglobe.id/news/indonesian-team-in-china-for-covid19-vaccine-safety-audit